These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27317459)

  • 1. Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children.
    Hankin-Wei A; Rein DB; Hernandez-Romieu A; Kennedy MJ; Bulkow L; Rosenberg E; Trigg M; Nelson NP
    Vaccine; 2016 Jul; 34(35):4243-4249. PubMed ID: 27317459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling study.
    Elbasha EH; Choi Y; Daniels V; Goveia MG
    Vaccine; 2021 Oct; 39(42):6315-6321. PubMed ID: 34538694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.
    Rein DB; Hicks KA; Wirth KE; Billah K; Finelli L; Fiore AE; Hoerger TJ; Bell BP; Armstrong GL
    Pediatrics; 2007 Jan; 119(1):e12-21. PubMed ID: 17200237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
    Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada.
    Ramsay LC; Anyiwe K; Li M; Macdonald L; Coyte PC; Sander B
    Vaccine; 2019 Mar; 37(11):1467-1475. PubMed ID: 30770225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico.
    Carlos F; Gómez JA; Anaya P; Romano-Mazzotti L
    Hum Vaccin Immunother; 2016; 12(1):52-63. PubMed ID: 26503702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of hepatitis A vaccination in Indonesia.
    Suwantika AA; Beutels P; Postma MJ
    Hum Vaccin Immunother; 2014; 10(8):2342-9. PubMed ID: 25424941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach.
    Dhankhar P; Nwankwo C; Pillsbury M; Lauschke A; Goveia MG; Acosta CJ; Elbasha EH
    Value Health; 2015 Jun; 18(4):358-67. PubMed ID: 26091589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost-utility analysis on universal childhood hepatitis A vaccination in regions with different anti-HAV prevalence rates of China].
    Pan XJ; Feng YM; Zhuang GH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):862-6. PubMed ID: 22967346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
    Postma MJ; Bos JM; Beutels P; Schilthuis H; van den Hoek JA
    Vaccine; 2004 May; 22(15-16):1862-7. PubMed ID: 15121296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis A vaccination coverage among adolescents (13-17 years) in the United States, 2008-2016.
    Nelson NP; Yankey D; Singleton JA; Elam-Evans LD
    Vaccine; 2018 Mar; 36(12):1650-1659. PubMed ID: 29449100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted.
    Ellis A; Rüttimann RW; Jacobs RJ; Meyerhoff AS; Innis BL
    Rev Panam Salud Publica; 2007 Jun; 21(6):345-56. PubMed ID: 17761046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-effectiveness analysis of revaccination and catch-up strategies with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in older adults in Japan.
    Jiang Y; Yang X; Taniguchi K; Petigara T; Abe M
    J Med Econ; 2018 Jul; 21(7):687-697. PubMed ID: 29723081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies.
    Anonychuk AM; Tricco AC; Bauch CT; Pham B; Gilca V; Duval B; John-Baptiste A; Woo G; Krahn M
    Pharmacoeconomics; 2008; 26(1):17-32. PubMed ID: 18088156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
    Cody P; Tobe K; Abe M; Elbasha EH
    BMC Infect Dis; 2021 Jan; 21(1):11. PubMed ID: 33407188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France.
    Lecocq H; Parent du Châtelet I; Taha MK; Lévy-Bruhl D; Dervaux B
    Vaccine; 2016 Apr; 34(19):2240-50. PubMed ID: 27002504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China.
    Zhuang GH; Pan XJ; Wang XL
    Vaccine; 2008 Aug; 26(35):4608-16. PubMed ID: 18597903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.
    Jia Y; Li L; Cui F; Zhang D; Zhang G; Wang F; Gong X; Zheng H; Wu Z; Miao N; Sun X; Zhang L; Lv J; Yang F
    Hum Vaccin Immunother; 2014; 10(10):2983-91. PubMed ID: 25483678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.